10 Impact of hemoglobin (Hgb) level and use of recombinant human erythropoietin (r-HuEPO) on response to neoadjuvant chemoradiation therapy, tumor control, and survival in patients with oral or oropharyngeal squamous cell carcinoma (SCCA)
C.M. Glaser, W. Millesi, G.V. Kornek, S. Lang, B. Schüll, K. Klug, F. Wanschitz, R.S. LaveyVolume:
45
Year:
1999
Language:
english
Pages:
2
DOI:
10.1016/s0360-3016(99)90028-7
File:
PDF, 287 KB
english, 1999